Intraoperative tracheal injury is a rare but potentially devastating complication. Transhiatal esophagectomy should be avoided in patients with proximal esophageal tumors who underwent neoadjuvant therapy, and percutaneous tracheostomy should be avoided in patients with short, thick necks. Early recognition leads to improved outcomes. Patients present with a sudden loss in airway pressure, air leaking into the operative field, or mediastinal and subcutaneous emphysema. Treatment starts with airway control. Primary buttressed repair is recommended, through either a left cervical incision for proximal injuries or a right thoracotomy for distal injuries. Nonoperative management has been used safely in select patients injured during intubation or tracheostomy.

Oesophageal cancer is the eighth most commonly diagnosed cancer worldwide, and there is a need for biomarkers to improve diagnosis, prognosis and treatment. Sulfatases 2 (SULF2) is an extracellular endosulphatase that regulates several signalling pathways in carcinogenesis and has been associated with poor prognosis. This study evaluates the relationship between SULF2 expression by immunohistochemistry and overall survival in patients with oesophageal cancer.Cohort study.Single tertiary care centre.We included patients who underwent esophagectomy for invasive oesophageal adenocarcinoma and squamous cell carcinoma at a tertiary care centre from 1997 to 2006. We excluded patients with recurrent oesophageal cancer or less than 3 mm invasive tumour on HE stained slide. A section from each paraffin-embedded tissue specimen was stained with an anti-SULF2 monoclonal antibody.A pathologist blinded to overall survival determined the percentage and intensity of tumour cells staining. Vital status was obtained through the Social Security Death Master File, and overall survival was calculated from the date of surgery.One-hundred patients with invasive oesophageal cancer were identified, including 75 patients with adenocarcinoma and 25 patients with squamous cell carcinoma. The squamous cell carcinoma samples had a higher mean percentage and intensity of tumour cells staining compared with the adenocarcinoma samples. After adjusting for age, sex, race, histological type, stage and neoadjuvant therapy, for every 10% increase in percentage of tumour cells staining for SULF2, the HR for death increased by 13% (95% CI 1.01 to 1.25; p=0.03).The majority of adenocarcinoma samples and all of the squamous cell carcinoma samples had SULF2 staining. The percentage of tumour cells staining for SULF2 was significantly associated with overall survival. Thus, SULF2 is a potential biomarker in oesophageal cancer and may have an important role in the management of patients with this disease.

Supercharge your law library’s ability to find and deliver information to stakeholders.
Convergence for Law Firms
is an intuitive web monitoring tool that uncovers highly targeted and relevant content from thousands of different sources. You’ll leverage powerful pre-defined taxonomy searches along with your own, specific keywords to uncover JUST the information you need to find.

And with its powerful distribution capabilities you’ll automatically send finely curated reports to the right professionals that meet the exact information needs of your firm.

Monitoring regulatory change is a critical compliance function, and if your company is like most your compliance team spends at least 40 hours per month on web research. Staying current on your regulatory obligations and getting the right information to the right compliance team members, is an expensive, tedious, error-prone process that keeps your compliance team from doing real, valuable work.

Convergence for Compliance
is a specialized web monitoring tool for compliance and risk management professionals designed specifically to improve the process of identifying regulatory change. Its unique capability searches a comprehensive list of regulatory bodies, agencies and associations to keep your compliance team on top of regulatory change, interpretation, actions, and more as it happens.

Designed by compliance professionals,
Convergence for Compliance
is powered by data scientists and taxonomists to deliver real results that match your regulatory profile exactly – it’s all the regulatory updates you need without the noise or time spent in web searching.

"Supercharge your library’s ability to find and deliver information. BNAConvergence enables you to create branded reports using their taxonomy searches, your keywords. Now on a daily basis we can send automated and curated reports meeting the information needs of users. They system is easy to learn and coupled with excellent customer service."

Winnebago's® continuing program of product improvement makes specifications, equipment, model availability, and prices subject to change without notice.Published content reflects the most current product information at time of printing. Please consult your dealer for individual vehicle features and specifications.